Call 408.493.1800 | Fax 408.493.1801 | Toll Free 800.891.9699 (US Only) | Email: [email protected]


Anti-PD-1 (Pembrolizumab) Biotinylated Antibody

Affinity purified recombinant monoclonal antibody to detect biotinylation of PD-1 in human samples
Catalog #: A2073

Product Details

Cat # +Size A2073-50
Size 50 μg
Antibody Target PD-1 (Pembrolizumab)
Host Recombinant
Antibody Type Monoclonal
Isotype Human IgG4
Immunogen Human programmed cell death 1 receptor (PD-1)
Accession # Q02242
Gene ID 18566
Appearance Colorless liquid
Concentration 0.5 mg/ml
Formulation In PBS, 30% glycerol, 0.5% BSA, 0.5 mM EDTA and 0.03% proclin, pH 7.2
Purification Affinity purified
Species Reactivity Human
Application ELISA
Application & Usage ELISA 0.5 - 1 µg/ml
Handling The antibody solution should be gently mixed before use.
Storage Conditions -20ºC
Shipping Conditions Gel Pack
USAGE For Research Use Only! Not For Use in Humans.


Pembrolizumab (Keytruda) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with unresectable or metastatic melanoma. Pembrolizumab binds to the human cell surface receptor PD-1 (Programmed Cell Death Protein 1) and blocks its interaction with PD-L1, resulting in the activation of T-cell-mediated immune responses against tumor cells.

Why buy BioVision Products?
Global Presence
Technical Support
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways.
BioVision is committed to providing the highest quality products at a competitive price.
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery.
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently.